Xcout Intel
KayoThera, Inc. competitors & alternatives
The 12 closest competitors and alternatives to KayoThera, Inc. among drug discovery companies — ranked by similarity to what KayoThera, Inc. actually does, not by market-cap band.
Subscribe to see KayoThera, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About KayoThera, Inc.
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
KayoThera, Inc. at a glance
KayoThera, Inc. is a drug discovery company headquartered in United States. Its most recent funding round, Series A, raised $5.2M in July 2023. Xcout tracks 5 named people at KayoThera, Inc., including Thong Q. Le (President & CEO).
KayoThera, Inc. leadership
- Thong Q. LePresident & CEO
- Mark EspositoResearcher / Founder
- Yibin KangProfessor / Founder
- Bruce L A CarterChairman
- Paul SekhriBoard Member
KayoThera, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5.2M | 3 named | |
| SEC Form D filing | $4M | — | |
| Series A | $10.5M | 1 named | |
| SEC Form D filing | $750,000 | — | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 KayoThera, Inc. competitors
Ranked by semantic similarity — how close each company is to KayoThera, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biopharma
Bonum Therapeutics, Inc. is a startup holding company operating in the therapeutics and drug pipeline sector in Washington, United States.
Similar drug discovery company
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Similar drug discovery company
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Similar drug discovery company
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Similar drug discovery company
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.
Similar drug discovery company
Kainova Therapeutics, formerly known as Domain Therapeutics, is a clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company drives a clinical pipeline of advanced GPCR-modulating therapies to address unmet medical needs.
Similar drug discovery company
Cyrus Biotechnology, Inc. is a biotechnology company with a corporate office located on 2nd Avenue in Seattle, Washington, United States. The firm provides advanced computational biology software and services.
Similar drug discovery company
Bridge Medicines LLC is a drug discovery holding company headquartered in New York, NY, that accelerates the path of therapeutic pipelines from research to patients.
Similar drug discovery company
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Similar drug discovery company
Retrotope, Inc. is a drug development company headquartered in Los Altos, California, focused on creating therapeutics for degenerative diseases.
Similar drug discovery company
Aneira Pharma, Inc. is a privately held pharmaceutical company founded in 2008 with its headquarters in San Diego, California.
Similar drug discovery company
Nura Bio Inc. is a privately held biopharmaceutical company headquartered in South San Francisco, California, founded in 2018 to develop novel treatments for neurological diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of KayoThera, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for KayoThera, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →